Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 807

Pouvelle B, Spiegel R, Hsiao L, Howard RJ, Morris RL, Thomas AP, Taraschi TF (1991) Direct
access to serum macromolecules by intraerythrocytic malaria parasites. Nature 353: 73-75
Pouvelle B, Matarazzo V, Jurzynski C, Nemeth J, Ramharter M, Rougon G, Gysin J (2007) Neural
cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum -infected
erythrocytes capable of aggregation. Infect Immun 75: 3516-3522
Pradel G, Garapaty S, Frevert U (2002) Proteoglycans mediate malaria sporozoite targeting to the
liver. Mol Microbiol 45: 637-651
Prieto MJ, Bacigalupe D, Pardini O, Amalvy JI, Venturini C, Morilla MJ, Romero EL (2006)
Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent. Int J Pharm
326: 160-168
Prokesch RC, Hand WL (1982) Antibiotic entry into human polymorphonuclear leukocytes.
Antimicrob Agents Chemother 21: 373-380
Rakita RM, Jacques-Palaz K, Murray BE (1994) Intracellular activity of azithromycin against
bacterial enteric pathogens. Antimicrob Agents Chemother 38: 1915-1921
Ranjan A, Pothayee N, Seleem MN, Sriranganathan N, Kasimanickam R, Makris M, Riffle JS
(2009) In Vitro trafficking and efficacy of core-shell nanostructures for treating intracellular
Salmonella Infections. Antimicrob Agents Chemother 53: 3985-3988
Ranjan A, Pothayee N, Vadala TP, Seleem MN, Restis E, Sriranganathan N, Riffle JS,
Kasimanickam R (2010) Efficacy of amphiphilic core-shell nanostructures encapsulating gen-
tamicin in an in vitro Salmonella and Listeria intracellular infection model. Antimicrob Agents
Chemother 54: 3524-3526
Rannard S, Owen A (2009) Nanomedicine: Not a case of “One size fits all”. Nano Today 4:
382-384
Rapp C, Imbert P, Darie H, Simon F, Gros P, Debord T, Roué R (2003) Traitement par amphoté-
ricine B liposomale d´une leishmaniose cutanée contractée à Djibouti et résistante à
l´antimoniate de méglumine [Liposomal amphotericin B treatment of cutaneous leishmaniasis
contracted in Djibouti and resistant to meglumine antimoniate]. Bull Soc Pathol Exot 96:
209-211
Rastogi N, Blom Potar MC (1990) Intracellular bactericidal activity of ciprofloxacin and ofloxa-
cin against Mycobacterium tuberculosis H37Rv multiplying in the J-775 macrophage cell line.
Zbl Bakt 273: 195-199
Richter-Dahlfors A, Buchan AMJ, Finlay BB (1997) Murine salmonellosis studies by confocal
microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a
cytotoxic effect on phagocytes in vivo . J Exp Med 186: 569-580
Roberts RL, Fine RE, Sandra A (1993) Receptor-mediated endocytosis of transferrin at the blood-
brain barrier. J Cell Sci 104: 521-532
Rodriguez A, Samoff E, Rioult MG, Chung A, Andrews NW (1996) Host cell invasion by try-
panosomes requires lysosomes and microtubule/kinesin-mediated transport. J Cell Biol 134:
349-362
Rodrigues Coura J, de Castro SL (2002) A critical review on Chagas disease chemotherapy . Mem
Inst Oswaldo Cruz 97: 3-24
Rogueda PG (2005) Novel hydrofluoroalkane suspension formulations for respiratory drug deliv-
ery. Expert Opin Drug Deliv 2: 625-638
Rogueda PG, Traini D (2007) The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxi-
cology and effects. Expert Opin Drug Del 4: 595-606
Romero EL, Morilla MJ (2008) Drug delivery systems against leishmaniasis? Still an open ques-
tion. Expert Opin Drug Deliv 5(7): 805-823
Romero EL, Morilla MJ (2010) Nanotechnological approaches against Chagas disease. Adv Drug
Del Rev 62: 576-88
Rook GAW, Hernandez-Pando R (1996) The pathogenesis of tuberculosis. Annu Rev Microbiol
50: 259-284
Roseeuw E, Coessens V, Balazuc AM, Lagranderie M, Chavarot P, Pessina A, Neri MG, Schacht E,
Marchal G, Domurado D (2003) Synthesis, degradation, and antimicrobial properties of targeted
macromolecular prodrugs of norfloxacin. Antimicrob Agents Chemother 47: 3435-3441